Live chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
| Filed | Ticker | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|---|
| 2d ago | KYMR | BVF PARTNERS L P/IL Affiliate of Director | 1,630,658 | $189.91M | Jun 26, 2026 | Acquired upon the automatic conversion of private shares in connection with the Issuer's initial public offering on August 21, 2020. The private shares were acquired and fully paid for on March 11, 2020. | Discretionary |
| Filed | Ticker | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
3d ago Jun 26, 2026 | Kymera Therapeutics, Inc. | Sell · S | 51,858 | $106.50 | $5.52M | Mild sell-37 | ||
3d ago Jun 26, 2026 | Kymera Therapeutics, Inc. | Sell · S | 113,289 | $106.50 | $12.07M | Mild sell-37 | ||
3d ago Jun 26, 2026 | Kymera Therapeutics, Inc. | Sell · S | 627,597 | $106.50 | $66.84M | Mild sell-37 | ||
3d ago Jun 26, 2026 | Kymera Therapeutics, Inc. | Sell · S | 837,914 | $106.50 | $89.24M | Mild sell-37 | ||
3d ago Jun 24, 2026 | Kymera Therapeutics, Inc. | Buy · A | 6,068 | $0.00 | $0 | Neutral+2 | Deriv |